Skip to content
10-Q

Quarterly Report

APPLIED GENETIC TECHNOLOGIES CORP

0001193125-22-289919

← back to feed
Filed
Nov 21, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Nov 16, 2022 67.63M sh
Shares Diluted Q1 2023 · Sep 30, 2022 64.91M sh
Shares Diluted Q1 2023 · Sep 30, 2021 42.82M sh
Capex Q1 2023 · Sep 30, 2022 $183K
Capex Q1 2023 · Sep 30, 2021 $545K
Operating Cash Flow Q1 2023 · Sep 30, 2022 −$16.04M
Operating Cash Flow Q1 2023 · Sep 30, 2021 −$15.94M
Long Term Debt Q1 2023 · Sep 30, 2022 $6.81M
Long Term Debt Q1 2023 · Jun 30, 2022 $9.12M
Short Term Debt Q1 2023 · Sep 30, 2022 $9.53M
Short Term Debt Q1 2023 · Jun 30, 2022 $9.3M
Cash And Equivalents Q1 2023 · Sep 30, 2022 $34.24M
Cash And Equivalents Q1 2023 · Jun 30, 2022 $46.37M
Stockholders Equity Q1 2023 · Sep 30, 2022 $17.65M
Stockholders Equity Q1 2023 · Jun 30, 2022 $29.48M
Stockholders Equity Q1 2023 · Sep 30, 2021 $69.53M
Stockholders Equity Q1 2023 · Jun 30, 2021 $85.81M
Current Liabilities Q1 2023 · Sep 30, 2022 $26.6M
Current Liabilities Q1 2023 · Jun 30, 2022 $25.21M
Total Liabilities Q1 2023 · Sep 30, 2022 $39.69M
Total Liabilities Q1 2023 · Jun 30, 2022 $37.21M
Current Assets Q1 2023 · Sep 30, 2022 $37.24M
Current Assets Q1 2023 · Jun 30, 2022 $49.56M
Total Assets Q1 2023 · Sep 30, 2022 $57.33M
Total Assets Q1 2023 · Jun 30, 2022 $66.68M
Eps Diluted Q1 2023 · Sep 30, 2022 −$0.28
Eps Diluted Q1 2023 · Sep 30, 2021 −$0.40
Eps Basic Q1 2023 · Sep 30, 2022 −$0.28
Eps Basic Q1 2023 · Sep 30, 2021 −$0.40
Sga Expense Q1 2023 · Sep 30, 2022 $4.46M
Sga Expense Q1 2023 · Sep 30, 2021 $4.1M
Rd Expense Q1 2023 · Sep 30, 2022 $12.88M
Rd Expense Q1 2023 · Sep 30, 2021 $12.33M
Net Income Q1 2023 · Sep 30, 2022 −$18.41M
Net Income Q1 2023 · Sep 30, 2021 −$17.12M
Operating Income Q1 2023 · Sep 30, 2022 −$17.34M
Operating Income Q1 2023 · Sep 30, 2021 −$16.43M
Revenue Q1 2023 · Sep 30, 2022 $0
Revenue Q1 2023 · Sep 30, 2021 $0